Valerie Yang MBBChir PhD

A full house at 1st SingHealth Sarcoma and Skin Symposium at the National Cancer Centre Singapore, 19-20 July 2023. Wonderful to see so many people from all walks of life dedicated towards improving outcomes for our patients with #Sarcoma or #Skin Cancers! #rarecancer

🌟"ATLAS Monthly Webinar" series🌟 We are excited to announce the ATLAS Monthly Webinar! This seminar series aims to share the latest advancements in cancer research, and treatment. We look forward to your participation😊 Date: 2026/01/28 Registration: us06web.zoom.us/.../reg.../WN_…

@drdaviddwlee Congratulations David 👍💯

It’s been almost 2 weeks of transitioning into my new role at Sunway Medical Centre. Thank you for the support and I look forward to this new chapter.

Looking forward to discussing how we are pushing the boundaries in treating sarcomas and rare cancers - @val_yang @saxotomy @ATLAS_by_NCC oncodaily.com/blog/valerie-y… #Cancer #OncoDaily #Medicine #Oncology #MedEd #MedX #MedNews

How do we beat this devastating disease? Let’s talk! Thanks @ATLAS_by_NCC for the opportunity 💯💪

🌟"ATLAS Monthly Webinar" series🌟 We are excited to announce the ATLAS Monthly Webinar! This seminar series aims to share the latest advancements in cancer research, and treatment. We look forward to your participation😊 Date: 2025/03/27 Registration: en.atlas.ncc.go.jp/capacity_build…

💔Emotional Toll of Rare Cancers: Study by @val_yang Highlights the Need for Enhanced Support @astar_research @CellbiologyT oncodaily.com/url/163078 #RareCancer #PatientSupport #Cancer #MedEd #MedNews #Health #Medicine #MedTwitter #OncoDaily #Oncology

@oncodaily @astar_research @CellbiologyT Thank you @oncodaily for highlighting this important need!

‼️Coming up 🔜 @ctosociety Webinar on “Dedifferentiated Liposarcoma”- the 2024 #sarcoma of the year! Please join us for an in-depth overview of the state-of-the-art of DDLPS diagnostics, biology, and clinical management on October 10! Register here👇 ctos.org/EducationalPro…

@irhkch Congratulations @irhkch !

When there is a will there is a way! 👶🏻 Amazing to see the baby out of the incubator and running around as a toddler now 🤩 #PIR #saveslife #interventionalradiology #embolisation

@careforhana @oncodaily Yes I absolutely agree. A massive challenge to put fragmented data together, what more in rare cancers. What applies to Asia also differs from MENA - biology aside, access, reimbursement and healthcare logistics also make a huge difference.

🔈Dr. @val_yang introduces HaNSA—the Head and Neck Sarcoma Assessor. It's a game changer for guiding treatment decisions in rare cancers. Dive in and explore! oncodaily.com/blog/150072 #Cancer #HNCSM #MedEd #MedNews #Health #Medicine #MedTwitter #OncoDaily #Oncology

@saxotomy @pmcancercentre @lillian_siu @NationalLMSF Wowowow! Have a fantastic time Tom!!!

After 10 years, I am back! @pmcancercentre @lillian_siu for the #leiomyosarcoma @NationalLMSF #lmsresearchroundtable

No. HaNSA isn't the name of a Korean girl band🤣 It's the Head and Neck Sarcoma Assessor! This helps guide clinicians managing these rare cancers make treatment decisions. Scan the QR code to try this out for yourself! esmorwd.org/article/S2949-… #sarcoma #rarecancer #CTOSTweetos

@herbloong @myESMO @ctosociety @DrCeSarcoma Keep us posted @herbloong! Would have loved to have been there!

#Sarcoma miniorals at @myESMO #ESMO24 happening now! Come join us in #Alicante in Hall 3. #CTOSTweeTOS @ctosociety @DrCeSarcoma

People diagnosed with rare cancers more prone to suicides, PTSD: Research @val_yang  #valerieyang #sohkimhai #nationalcancercentresingapore #nationaluniversityofsingapore #indicanews indicanews.com/people-diagnos…

Such a pleasure to chair the Sarcoma Track at the @SSO_Singapore Annual Scientific Meeting 2024 - @val_yang @ASCO @SingHealthSG @astar_research @oncodaily @JB_Chiang oncodaily.com/117262.html #ASCO #cancerCare #cancer #OncoDaily #Oncology #SingaporeSocietyofOncology

To our patients: this may be rare, this may be challenging, but you are NOT alone - @val_yang @csi_singapore @JohnnyOngCA @ChiaClaramae @JB_Chiang oncodaily.com/blog/116087.ht… #Cancer #SarcomaAwareness #PatientAdvocacy #RareCancer #OncoDaily #Oncology

Afamicel, TCR targeting MAGEA-4 approved for #synovial sarcoma. A remarkable advancement for our patients, laying the foundation for future efforts in solid tumors. businesswire.com/news/home/2024…

Dr. Christopher Fletcher made an incredible impact on sarcoma research and the sarcoma community. We are deeply saddened by his passing and are immensely grateful for his remarkable contributions.

Pictured here at the #SARCtrials Semi-Annual Meeting at #CTOS this past November, Dr. Chris Fletcher has had an astounding impact on #sarcoma research and the sarcoma community. We are saddened to learn of his passing and are grateful for his amazing contributions.